Tarceva Trial EORTC 55041
Trial Description:
A randomised, multicentre, phase III study of Erlotinib versus observation in patients
with no evidence of disease progression after first line, platinum-based chemotherapy
for high-risk Stage I and Stage II-IV ovarian epithelial, primary peritoneal, or
fallopian tube cancer.
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Completed
Contact person:
ivergote